Belpointe Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-10,123
Closed -$1M 826
2019
Q3
$1M Buy
10,123
+6,506
+180% +$618K 0.16% 145
2019
Q2
$334K Sell
3,617
-1,739
-32% -$165K 0.07% 313
2019
Q1
$504K Sell
5,356
-125
-2% -$10.9K 0.1% 164
2018
Q4
$351K Sell
5,481
-532
-9% -$39.3K 0.09% 251
2018
Q3
$538K Buy
6,013
+1,459
+32% +$129K 0.09% 243
2018
Q2
$362K Buy
4,554
+460
+11% +$38.2K 0.1% 225
2018
Q1
$365K Sell
4,094
-1,706
-29% -$164K 0.11% 220
2017
Q4
$605K Buy
5,800
+14
+0.2% +$1.58K 0.13% 181
2017
Q3
$844K Buy
+5,786
New +$788K 0.2% 113

Other funds holding CELG

Belpointe Asset Management's CELG Position: Q4 2019 in Review

Belpointe Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 10,123 shares — an estimated $1M sold.

Belpointe Asset Management first reported a position in CELG in Q3 2017 and held it in 9 quarters. The position peaked at $1M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Belpointe Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Belpointe Asset Management sold 10,123 Celgene Corp shares in Q4 2019, an estimated $1M.
  • Belpointe Asset Management first reported a position in Celgene Corp in Q3 2017 and held it in 9 quarters.
  • Belpointe Asset Management's Celgene Corp position peaked at $1M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Belpointe Asset Management's 13F filing for Q4 2019, filed 18 Feb 2020.